Table 1.
Method | LGD | No dysplasia |
Personal interview | 15 | 37 |
Patient questionnaires | 1 | 12 |
Information from GP | 7 | 18 |
Review of current case notes | 3 | 17 |
Death certificate | 3 | 13 |
Total traceable | 29 | 97 |
Total non-traceable | 1 | 1 |
Total | 30 | 98 |